Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian P Danysh

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Plos One|April 18, 2012
Improved cellular specificity of plasmonic nanobubbles versus nanoparticles in heterogeneous cell systemsEkaterina Y Lukianova-Hleb, Xiaoyang Ren, Pamela E Constantinou, et al.
Cancers|October 13, 2021
<i>RAC1</i> Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer PatientRozita Bagheri-Yarmand, Naifa L Busaidy, Elena McBeath, et al.
Cancer Discovery|August 18, 2021
Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast CancerJames T Coates, Sheng Sun, Ignaty Leshchiner, et al.
Blood Advances|October 26, 2022
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistanceAishath Naeem, Filippo Utro, Qing Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|October 9, 2023
Germline mutations and developmental mosaicism underlying <i>EGFR</i>-mutant lung cancerRisa Burr, Ignaty Leshchiner, Christina L Costantino, et al.
Nature Cancer|October 15, 2024
Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumorsRisa Burr, Ignaty Leshchiner, Christina L Costantino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2025
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck CancerRitu Chaudhary, Graydon Moorhead, Robin Park, et al.
Blood|May 5, 2023
Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samplesJasneet Kaur Khalsa, Justin Cha, Filippo Utro, et al.
Nature Medicine|September 13, 2022
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphomaNicholas J Haradhvala, Mark B Leick, Katie Maurer, et al.
Cell Genomics|September 10, 2025
Detection of heterogeneous resistance mechanisms to tyrosine kinase inhibitors from cell-free DNAHeather A Parsons, Conor Messer, Katheryn Santos, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Plos One|April 18, 2012
Improved cellular specificity of plasmonic nanobubbles versus nanoparticles in heterogeneous cell systemsEkaterina Y Lukianova-Hleb, Xiaoyang Ren, Pamela E Constantinou, et al.
Cancers|October 13, 2021
<i>RAC1</i> Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer PatientRozita Bagheri-Yarmand, Naifa L Busaidy, Elena McBeath, et al.
Cancer Discovery|August 18, 2021
Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast CancerJames T Coates, Sheng Sun, Ignaty Leshchiner, et al.
Blood Advances|October 26, 2022
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistanceAishath Naeem, Filippo Utro, Qing Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|October 9, 2023
Germline mutations and developmental mosaicism underlying <i>EGFR</i>-mutant lung cancerRisa Burr, Ignaty Leshchiner, Christina L Costantino, et al.
Nature Cancer|October 15, 2024
Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumorsRisa Burr, Ignaty Leshchiner, Christina L Costantino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2025
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck CancerRitu Chaudhary, Graydon Moorhead, Robin Park, et al.
Blood|May 5, 2023
Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samplesJasneet Kaur Khalsa, Justin Cha, Filippo Utro, et al.
Nature Medicine|September 13, 2022
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphomaNicholas J Haradhvala, Mark B Leick, Katie Maurer, et al.
Cell Genomics|September 10, 2025
Detection of heterogeneous resistance mechanisms to tyrosine kinase inhibitors from cell-free DNAHeather A Parsons, Conor Messer, Katheryn Santos, et al.
Pageof 3